There were 145 press releases posted in the last 24 hours and 437,676 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Travere Therapeutics Provides Regulatory Update on its Sparsentan Program for IgA Nephropathy

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image